Pancreatic Cancer Research

ResearcherAffiliated Hospital of Qingdao UniversityNo recent work listed

Zibin Tian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4622-2114; OpenAlex author ID A5101593369. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Glutamine addiction and therapeutic strategies in pancreatic cancer. Last author DOI 10.4251/wjgo.v15.i11.1852↗
  2. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway. Last author DOI 10.18632/oncotarget.14633↗
  3. MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancer. Co-author DOI 10.3892/etm.2017.4770↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongyun Wei · 1 shared paper, 2023 · strength 0.22
  2. Linlin Ren · 1 shared paper, 2023 · strength 0.22
  3. Xiaoyu Li · 2 shared papers, 2017 · strength 0.13
  4. Cuiping Zhang · 2 shared papers, 2017 · strength 0.13
  5. Qinghui Niu · 2 shared papers, 2017 · strength 0.13
  6. Yueping Jiang · 1 shared paper, 2017 · strength 0.06
  7. Di Xia · 1 shared paper, 2017 · strength 0.06
  8. Guanglan Wang · 1 shared paper, 2017 · strength 0.06
  9. Bin Zhou · 1 shared paper, 2017 · strength 0.06
  10. Jun Wu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.